Elissa holds a bachelor's in biological sciences, a master's degree in engineering economic systems, and a doctorate in management science and engineering specializing in decision analysis and risk analysis from Stanford University. Prior to joining the Institute, she completed a post-doctoral fellowship at the Carol Franc Buck Breast Care Center at the University of California San Francisco Medical Center. Dr. Ozanne also has experience working with leading biotechnology companies in the California Bay Area including Entelos, Inc. and Pharsight, Inc. She also recently completed a fellowship with the ITA's Program for Cancer Outcomes Research Training (PCORT). In 2011, Elissa became an Assistant Professor, Department of Surgery and Institute for Health Policy Studies at the University of California, San Francisco.

Her research focuses on breast cancer decision-making including clinical decision aids, risk communication methods, cost-effectiveness and risk modeling, and the development of decision quality measures.

• Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: A comparative effectiveness analysis.
• Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
• Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
• How to define and measure concordance between patients' preferences and medical treatments: A systematic review of approaches and recommendations for standardization
• Breast Cancer Prevention: Patient Decision Making and Risk Communication in the High Risk Setting

• Cost-Effectiveness of Screening for BRCA 1/2 Mutations in High Risk Population
• Cost-Effectiveness of Chemopreventive Agents for Breast Cancer Prevention
• Clinical Decision Aid for Breast Cancer Prevention
• Breast Cancer Prevention Model
• Risk Communication Methods